Zobrazeno 1 - 10
of 64
pro vyhledávání: '"T A Mitina"'
Autor:
A K Golenkov, I V Buravtsova, G A Dudina, T D Lutskaia, T A Mitina, E V Kataeva, A F Karamysheva, E S Kakpakova, Iu A Sablina, A A Stavrovskaia
Publikováno v:
Терапевтический архив, Vol 85, Iss 7, Pp 98-102 (2013)
AIM: To determine the significance of the angiogenic activity estimated from the gene expression of the vascular endothelial growth factors (VEGFs) VEGF-A, VEGF-C, and VEGF-D and their receptors VEGFR1, VEGFR1s, VEGFR2, and VEGFR3 in the mononuclear
Externí odkaz:
https://doaj.org/article/bdc6bdb6258e41b39621d4f6dc48fb05
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 57-61 (2010)
Aim. To evaluate the effectiveness of bortezomib and bortezomib-containing treatment programs in the therapy of resistant and recurrent multiple myeloma (MM) within a large unicenter study in real clinical practice conditions. Subjects and methods. T
Externí odkaz:
https://doaj.org/article/a34873e0123a4b388baa16c96428a66b
Autor:
Anatoliy Konstantinovich Golenkov, Tat'yana Alekseevna Mitina, Ivetta Nikolaevna Kogarko, Nina Vasil'evna Lyubimova, Elena Fedorovna Klinushkina, Anatoliy Yur'evich Baryshnikov, A K Golenkov, T A Mitina, I N Kogarko, N V Lyubimova, E F Klikushkina, A Yu Baryshnikov
Publikováno v:
Терапевтический архив, Vol 81, Iss 7, Pp 37-41 (2009)
Aim. To ascertain individual sensitivity to veikeid in patients with resistant and recurrent multiple myeloma (MM) by determination of free light chains (FLC) of serum immunoglobulins. Material and methods. Forteen patients with MM stage III (Gcappa-
Externí odkaz:
https://doaj.org/article/8f9d4f0217fc4eca82cfca274c253e15
Autor:
T A Mitina, A K Golenkov
Publikováno v:
Терапевтический архив, Vol 80, Iss 7, Pp 48-50 (2008)
Aim. To assess efficacy of velcade monotherapy in patients with resistent and recurrent multiple myeloma (MM). Material and methods. Velcade was given to 29 patients (11 males and 18 females at the age 41-73 years) with resistant and recurrent MM of
Externí odkaz:
https://doaj.org/article/556b444dfff74293baee1aee566b7986
Autor:
S. G. Zakharov, T. A. Mitina, R. V. Vardanyan, I. N. Kontievskiy, A. P. Faenko, Z. R. Tekeeva
Publikováno v:
Онкогематология, Vol 17, Iss 4, Pp 33-37 (2022)
Background. Idiopathic thrombocytopenic purpura (ITp) is an autoimmune disease characterized by antibody-mediated platelets destruction and impairment of their production, which manifests itself as: isolated thrombocytopenia, risk of spontaneous hemo
Externí odkaz:
https://doaj.org/article/bd5dc8d312224c1ca4702c3c58a7e1cb
Publikováno v:
Медицинская иммунология, Vol 22, Iss 6, Pp 1185-1194 (2021)
B cell stimulation develops upon vaccination, thus causing occurrence of activated B cells (plasmoblasts) in bloodstream. Similar cells are also observed in some viral infections. The contents of plasmablasts may be a marker of successful vaccination
Externí odkaz:
https://doaj.org/article/1867c803dbf04ec9a7ef72642db324de
Autor:
O. M. Drapkina, A. I. Martynov, A. P. Baida, V. E. Balan, I. I. Baranov, E. E. Vlasova, P. A. Vorobiev, S. A. Volkova, I. Yu. Gaiduk, Zh. A. Gornostaeva, N. Yu. Grigorieva, Yu. E. Dobrokhotova, L. I. Dvoretskiy, G. B. Dikke, V. F. Dolgushina, O. V. Dunicheva, E. V. Eliseeva, E. V. Ivanova, N. A. Koryagina, T. A. Kunyaeva, V. I. Kupaev, T. A. Mitina, M. E. Mozheiko, T. A. Oboskalova, S. V. Orlova, T. Yu. Pestrikova, N. P. Sanina, E. I. Sas, G. Sh. Safuanova, T. M. Sokolova, N. I. Stuklov, N. L. Tov, L. V. Tribuntseva, Z. A. Umarova, L. S. Fatkullina, A. V. Fendrikova, O. V. Khlynova, G. V. Shavkuta, Yu. A. Sharapova, E. V. Shikh, R. N. Shepel, A. N. Kaburova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 5 (2020)
It is known that iron deficiency is a negative factor for the onset of pregnancy. It aggravates its course, increasing the risk of preeclampsia, placental insufficiency, uterine inertia, premature birth, bleeding and hypogalactia. This condition incr
Externí odkaz:
https://doaj.org/article/59a3257c7daf477d81064af368ac9d52
Publikováno v:
Transplantologiya. The Russian Journal of Transplantation. 14:195-209
One of the greatest medical advances of the last century has been the introduction of organ transplantation. However, despite the considerable potential of transplantation as often the only therapy for severe diseases, the toxicity of immunosuppressi
Publikováno v:
Russian journal of hematology and transfusiology. 66:20-36
Introduction. The COVID-19 pandemic has challenged health professionals and patients suffering from haematological diseases with embarrassed diagnosis, treatment, surveillance, social distancing and other constraints.Aim — addressing therapy for im
Autor:
V. P. Voloshin, S. A. Oshkukov, D. V. Martynenko, E.V. Stepanov, K. V. Shevyrev, T. A. Mitina, D. A. Shavyrin, E. V. Trifonova
Publikováno v:
Гений oртопедии, Vol 27, Iss 2, Pp 265-269 (2021)
Introduction Multiple myeloma (MM) is a malignant tumor that causes widespread bone damage. The bone is involved in 90 % of MM patients, and 60% of patients develop pathologic fractures. Material and methods We report a case of combined surgical trea